ArticleCurrent oncology (Toronto, Ont.)2024

Early Changes in Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Are Useful Predictors of Antitumor Response to Durvalumab Plus Tremelimumab Therapy for Advanced Hepatocellular Carcinoma.

Teiji Kuzuya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.